Paediatric tumour boards in Spain: a national survey

Data de publicació: 01/09/2016

Autors de IIS La Fe

Pablo Berlanga Charriel

Autor
Vanessa Segura Caballer

Autor
Antonio Juan Ribelles

Autor
Victoria Castel Sánchez

Autor
Adela Cañete Nieto

Autor

Autors aliens a IIS La Fe

de Toledo, PS
Acha, T

Grups d'Investigació

Investigación Clínica y Traslacional en Cáncer

Leader

José Gómez Codina

Abstract

Multidisciplinary tumour boards (MDTs) are conducted worldwide for the management of patients with cancer, and they deliver a higher standard of care by simultaneously involving different specialists in diagnosis and treatment planning. However, information of paediatric MDTs functioning is scarce. A pilot study was conducted in Spain in the frame of the European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment (ExPO-r-Net). A specific questionnaire was designed regarding various features of MDT practice. Data collected included information on the centres and the team, infrastructure for meetings, MDT organization/logistics and clinical decision-making. The survey was distributed to all Paediatric Oncology Units that register patients in the Spanish Registry of Childhood Tumours (RETI-SEHOP). 32 out of 43 contacted centres responded the questionnaire (74 % response rate; 88 % response rate for centres with > 25 new patients/year). All units with > 25 new patients/year have a dedicated Paediatric MDT compared to 76 % of units with aecurrency sign25 new patients/year. MDTs should be improved at institutional level by clear protected time in service planning for all specialists involved, incentives for attendance and attendance registration. Clinical decision-making process and follow-up of recommendation adherence should be assessed and potential legal responsibilities for physicians participating in Tumour Board defined. Network collaboration through virtual MDTs, using available videoconferencing tools, is an opportunity to share expertise among centres.

Dades de la publicació

ISSN/ISSNe:: 1699-048X, 1699-3055
Tipus:: Article
Pàgines:: 931-936
DOI:: 10.1007/s12094-015-1466-9
PubMed:: 26693730
Factor d'Impacte:: 0,774 SCImago ℠
Quartil:: Q2 SCImago ℠

Documents

No hi ha documents

Mètriques

Filiacions

Berlanga, P:: Hosp Univ & Politecn La Fe, Paediat Oncol Unit, Valencia, Spain

Instituto de Investigación. Inst Invest Sanitaria La Fe, Valencia, Spain
Segura, V:: Instituto de Investigación. Inst Invest Sanitaria La Fe, Valencia, Spain
Ribelles, AJ:: Hosp Univ & Politecn La Fe, Paediat Oncol Unit, Valencia, Spain

Instituto de Investigación. Inst Invest Sanitaria La Fe, Valencia, Spain
de Toledo, PS:: Hosp Univ Vall dHebron, Paediat Oncol Unit, Barcelona, Spain
Acha, T:: Hosp Carlos Haya, Paediat Oncol Unit, Malaga, Spain
Castel, V:: Instituto de Investigación. Inst Invest Sanitaria La Fe, Valencia, Spain
Canete, A:: Hosp Univ & Politecn La Fe, Paediat Oncol Unit, Valencia, Spain

Instituto de Investigación. Inst Invest Sanitaria La Fe, Valencia, Spain